“…HER2neu overexpression was negative in all 6 reported cases [1,3,5,39]. In comparison, immunoreactivity for ER, PR, and HER2neu in 29 cases of histiocytoid breast carcinoma was 44,19, and 57%, respectively [21,22,26,29,[31][32][33][34][43][44][45][46].…”